Id |
Subject |
Object |
Predicate |
Lexical cue |
T11 |
0-12 |
Sentence |
denotes |
INTRODUCTION |
T1054 |
13-284 |
Sentence |
denotes |
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with a typical three phased course (chronic, accelerated and blastic phase) reflecting the loss of differentiation and malignant progress which inevitably leads to death after the blastic phase (1,2). |
T12 |
13-284 |
Sentence |
denotes |
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with a typical three phased course (chronic, accelerated and blastic phase) reflecting the loss of differentiation and malignant progress which inevitably leads to death after the blastic phase (1,2). |
T1055 |
285-464 |
Sentence |
denotes |
The hallmark genetic aberration of CML is a reciprocal chromosomal translocation t(9;22) leading to expression of a bcr-abl fusion gene, an aberrant activated tyrosine kinase (2). |
T13 |
285-464 |
Sentence |
denotes |
The hallmark genetic aberration of CML is a reciprocal chromosomal translocation t(9;22) leading to expression of a bcr-abl fusion gene, an aberrant activated tyrosine kinase (2). |
T1056 |
465-621 |
Sentence |
denotes |
Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogenetic response in 5–33% of CML patients (1,2). |
T14 |
465-621 |
Sentence |
denotes |
Treatment with interferon α (IFN-α) prolongs survival of CML patients and is associated with a complete cytogenetic response in 5–33% of CML patients (1,2). |
T1057 |
622-776 |
Sentence |
denotes |
Recently, we described an impaired expression of the interferon regulatory factor 4 (IRF-4) in CML, correlating with poor response to IFN-α treatment (3). |
T15 |
622-776 |
Sentence |
denotes |
Recently, we described an impaired expression of the interferon regulatory factor 4 (IRF-4) in CML, correlating with poor response to IFN-α treatment (3). |
T1058 |
777-836 |
Sentence |
denotes |
The cause of the silencing of IRF-4 level remained unclear. |
T16 |
777-836 |
Sentence |
denotes |
The cause of the silencing of IRF-4 level remained unclear. |
T1059 |
837-982 |
Sentence |
denotes |
Interferon regulatory factors (IRFs) are a family of transcriptional regulators defined by a characteristic homology in their DNA-binding domain. |
T17 |
837-982 |
Sentence |
denotes |
Interferon regulatory factors (IRFs) are a family of transcriptional regulators defined by a characteristic homology in their DNA-binding domain. |
T1060 |
983-1139 |
Sentence |
denotes |
They play an important role in the regulation of various genes (such as IFNs, interleukins, MHC class I/II), apoptosis and differentiation/maturation (4–6). |
T18 |
983-1139 |
Sentence |
denotes |
They play an important role in the regulation of various genes (such as IFNs, interleukins, MHC class I/II), apoptosis and differentiation/maturation (4–6). |
T1061 |
1140-1223 |
Sentence |
denotes |
IRF-4 (ICSAT/Pip/MUM1/LSIRF) is one member with very restricted expression pattern: |
T19 |
1140-1223 |
Sentence |
denotes |
IRF-4 (ICSAT/Pip/MUM1/LSIRF) is one member with very restricted expression pattern: |
T1062 |
1224-1295 |
Sentence |
denotes |
Predominately B- and activated T-lymphocytes are IRF-4 positive (7–11). |
T20 |
1224-1295 |
Sentence |
denotes |
Predominately B- and activated T-lymphocytes are IRF-4 positive (7–11). |
T1063 |
1296-1474 |
Sentence |
denotes |
In contrast to other IRFs, expression of IRF-4 cannot be induced by IFNs, but by antigen stimulation, crosslinking of T- or B-cell receptors or phorbol-myristate-acetate (10,11). |
T21 |
1296-1474 |
Sentence |
denotes |
In contrast to other IRFs, expression of IRF-4 cannot be induced by IFNs, but by antigen stimulation, crosslinking of T- or B-cell receptors or phorbol-myristate-acetate (10,11). |
T1064 |
1475-1734 |
Sentence |
denotes |
Consistent with the restriction of expression to immunocompetent cells, mice with deletion of IRF-4 failed to develop mature and functionally active B- and T-lymphocytes (12), and the impaired expression of IRF-4 in CML was predominately found in T-cells (3). |
T22 |
1475-1734 |
Sentence |
denotes |
Consistent with the restriction of expression to immunocompetent cells, mice with deletion of IRF-4 failed to develop mature and functionally active B- and T-lymphocytes (12), and the impaired expression of IRF-4 in CML was predominately found in T-cells (3). |
T1065 |
1735-1811 |
Sentence |
denotes |
These data suggest a crucial role for IRF-4 in the function of immune cells. |
T23 |
1735-1811 |
Sentence |
denotes |
These data suggest a crucial role for IRF-4 in the function of immune cells. |
T1066 |
1812-2048 |
Sentence |
denotes |
Methylation of dinucleotide cytosine-guanosine motifs (CpG), especially in CpG islands located in promoter regions, is one of the mechanisms of gene regulation in mammals and a common event of gene silencing in human neoplasias (13,14). |
T24 |
1812-2048 |
Sentence |
denotes |
Methylation of dinucleotide cytosine-guanosine motifs (CpG), especially in CpG islands located in promoter regions, is one of the mechanisms of gene regulation in mammals and a common event of gene silencing in human neoplasias (13,14). |
T1067 |
2049-2166 |
Sentence |
denotes |
As opposed to normal cells, hypermethylation of CpG islands is a frequently observed phenomenon in every cancer type. |
T25 |
2049-2166 |
Sentence |
denotes |
As opposed to normal cells, hypermethylation of CpG islands is a frequently observed phenomenon in every cancer type. |
T1068 |
2167-2330 |
Sentence |
denotes |
De novo DNA methylation of genes such as cell cycle, DNA repair, apoptosis and tumor suppressor genes is therefore thought to be involved in tumorigenesis (15–17). |
T26 |
2167-2330 |
Sentence |
denotes |
De novo DNA methylation of genes such as cell cycle, DNA repair, apoptosis and tumor suppressor genes is therefore thought to be involved in tumorigenesis (15–17). |
T1069 |
2331-2441 |
Sentence |
denotes |
Examples for such aberrated genes are MGMT, DAPK, p14ARF, p15INK4b, p16INK4a, BRCA1, CDH13 and APAF-1 (17–19). |
T27 |
2331-2441 |
Sentence |
denotes |
Examples for such aberrated genes are MGMT, DAPK, p14ARF, p15INK4b, p16INK4a, BRCA1, CDH13 and APAF-1 (17–19). |
T1070 |
2442-2652 |
Sentence |
denotes |
In CML, methylation is known to regulate expression of the c-abl, the bcr gene and others (20–23), and the extent of methylation in the c-abl promoter has been shown to be associated with advanced disease (24). |
T28 |
2442-2652 |
Sentence |
denotes |
In CML, methylation is known to regulate expression of the c-abl, the bcr gene and others (20–23), and the extent of methylation in the c-abl promoter has been shown to be associated with advanced disease (24). |
T1071 |
2653-2800 |
Sentence |
denotes |
Hypermethylation due to overexpression of DNA methyltransferases (DNMTs) remains one possible explanation for de novo methylation in tumorigenesis. |
T29 |
2653-2800 |
Sentence |
denotes |
Hypermethylation due to overexpression of DNA methyltransferases (DNMTs) remains one possible explanation for de novo methylation in tumorigenesis. |
T1072 |
2801-2887 |
Sentence |
denotes |
Recently, DNMTs have been shown to be up-regulated in hematopoietic malignancies (25). |
T30 |
2801-2887 |
Sentence |
denotes |
Recently, DNMTs have been shown to be up-regulated in hematopoietic malignancies (25). |
T1073 |
2888-3099 |
Sentence |
denotes |
Methyl-CpG-binding proteins (MBPs) are thought to inhibit the binding of transcriptional factors to the promoter and are therefore discussed as one mechanism of transcription inhibition by hypermethylation (26). |
T31 |
2888-3099 |
Sentence |
denotes |
Methyl-CpG-binding proteins (MBPs) are thought to inhibit the binding of transcriptional factors to the promoter and are therefore discussed as one mechanism of transcription inhibition by hypermethylation (26). |
T1074 |
3100-3189 |
Sentence |
denotes |
In this work, we studied mechanisms of IRF-4 gene expression silencing in leukemic cells. |
T32 |
3100-3189 |
Sentence |
denotes |
In this work, we studied mechanisms of IRF-4 gene expression silencing in leukemic cells. |
T1075 |
3190-3329 |
Sentence |
denotes |
We analyzed the IRF-4 promoter region for genetic aberrations and methylational status in IRF-4-positive and -negative hematopoietic cells. |
T33 |
3190-3329 |
Sentence |
denotes |
We analyzed the IRF-4 promoter region for genetic aberrations and methylational status in IRF-4-positive and -negative hematopoietic cells. |